Engineered immune cells take on deadly brain tumors in first human test
Disease control
Recruiting now
This early-stage trial tests a new treatment called E-SYNC CAR T cells for people with a specific type of glioblastoma brain cancer. The therapy uses a patient's own immune cells, modified in a lab to better recognize and attack the tumor. About 20 adults will receive the cells a…
Phase: PHASE1 • Sponsor: Hideho Okada, MD, PhD • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC